Form 4: Guardant Health Director Meghan Joyce Reports Stock Transactions
SEC Form 4 Filing
Director Meghan Joyce reported the acquisition and disposition of Guardant Health, Inc. stock on March 4, 2024, including sales under a pre-arranged 10b5-1 plan.
Summary
- On March 4, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., reported transactions involving the company's common stock.
- Joyce acquired 66 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.
- Simultaneously, Joyce sold 100 shares of common stock at a price of $19.05 per share, under a pre-arranged sales plan pursuant to Rule 10b5-1.
- Following these transactions, Joyce directly owns 4,521 shares of Guardant Health, Inc. common stock.
- Joyce also owns 1,129 restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a routine disclosure of stock transactions by a company director. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The sale was conducted under a pre-arranged 10b5-1 plan, which is a common practice to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| August 4, 2022 | Date when 25% of the restricted stock units vested, with the remaining 75% vesting in substantially equal installments on each monthly anniversary for three years. |
| 03/04/2024 | Date of the reported stock transactions: acquisition of 66 shares via RSU vesting and sale of 100 shares at $19.05. |
| 03/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.